3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
4
Metastatic Castration-resistant Prostate Cancer
2
Breast Neoplasms
2
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Fanconi Anemia, Complementation Group D1
1
Endometrial Neoplasms
1
Interventions
Cetuximab
5
Bevacizumab
4
pembrolizumab
3
Leucovorin
3
Irinotecan
3
Fluorouracil
3
trifluridine tipiracil drug combination
2
trastuzumab deruxtecan
2
larotrectinib
2
encorafenib
2
binimetinib
2
Trastuzumab
2
Oxaliplatin
2
Nivolumab
2
HMPL-013
2
Afatinib
2
ulixertinib
1
tucatinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sotorasib
1
sapanisertib
1
relatlimab
1
regorafenib
1
pralsetinib
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
ipatasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Colorectal Neoplasms
×
olaparib
×
Clear all
No trials found.